Clinical trials
Non-Muscle Invasive Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
282 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 7 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 7 |
| 2015 | 8 |
| 2016 | 8 |
| 2017 | 8 |
| 2018 | 13 |
| 2019 | 22 |
| 2020 | 17 |
| 2021 | 17 |
| 2022 | 21 |
| 2023 | 29 |
| 2024 | 22 |
| 2025 | 31 |
| 2026 | 32 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 78 |
| Completed | 77 |
| Unknown status | 32 |
| Active, not recruiting | 29 |
| Not yet recruiting | 29 |
| Terminated | 23 |
| Withdrawn | 11 |
| Available | 2 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UroGen Pharma Ltd. | 11 |
| Mansoura University | 10 |
| ImmunityBio, Inc. | 7 |
| Janssen Research & Development, LLC | 7 |
| CG Oncology, Inc. | 4 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Pfizer | 4 |
| Protara Therapeutics | 4 |
| University of Rome Tor Vergata | 4 |
| AstraZeneca | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 282 |
| Urinary Bladder Neoplasms | 146 |
| Carcinoma, Transitional Cell | 26 |
| Neoplasms | 23 |
| Recurrence | 22 |
| Carcinoma in Situ | 18 |
| Urologic Neoplasms | 15 |
| Urinary Bladder Diseases | 11 |
| Disease Progression | 10 |
| Urologic Diseases | 9 |
Trials
Showing 76 to 100 of 282. Each trial links to its page on Pharma Observatory.
182 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.